Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The number of people with of asthma and allergy is still increasing and a large number of
patients still do not have their asthma well controlled. There is therefore a need for new
asthma treatments that work well and have less side effects. The study compares a new
experimental drug RPL554 with a marketed asthma drug (salbutamol) and placebo.